Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-04523655 in Diabetic Macular Edema (MATISSE)
NCT01445899Phase 2Completed
- Sponsor
- Quark Pharmaceuticals
- Start
- Feb 2012
- Primary completion
- Nov 2013
- Countries
- 7
01
Overview
A Phase 2 trial of PF-04523655 in diabetic macular edema (DME), sponsored by Quark Pharmaceuticals. Started Feb 2012; status: completed.
02
Drugs
PF-04523655
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01445899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01445899.